Russell Investments Group, Ltd. Bio Xcel Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$1.95 - $4.04 $499 - $1,034	256 Added 290.91%	344 $0
Q4 2023 Feb 05, 2024	BUY	$2.32 - $5.51 $204 - $484	88 New	88 $0
Q1 2023 May 09, 2023	BUY	$17.7 - $33.24 $3,681 - $6,913	208 New	208 $3,000
Q3 2021 Nov 08, 2021	SELL	$23.84 - $32.03 $15,424 - $20,723	-647 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$29.06 - $38.83 $563,124 - $752,447	-19,378 Reduced 96.77%	647 $18,000
Q1 2021 May 10, 2021	SELL	$39.04 - $64.6 $75,659 - $125,194	-1,938 Reduced 8.82%	20,025 $862,000
Q4 2020 Feb 08, 2021	BUY	$42.46 - $56.58 $513,511 - $684,278	12,094 Added 122.55%	21,963 $1.02 Million
Q2 2020 Aug 05, 2020	SELL	$17.62 - $58.71 $171,654 - $571,952	-9,742 Reduced 49.68%	9,869 $521,000
Q1 2020 May 06, 2020	BUY	$12.26 - $41.14 $240,430 - $806,796	19,611 New	19,611 $440,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $12.6M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.